Since Cyps represent the main targets of CypIs, the neutralization of the peptidyl–prolyl isomerase activity of specific members of the Cyp family is likely to be the cause for the anti-HCC activity of rencofilstat. This evidence concerns the gene PPIG and hepatocellular carcinoma.